Nupathe Inc : * Shares up 34.7 percent premarket after takeover proposal from Teva Pharmaceutical
NuPathe, Inc. develops therapeutics for diseases of the central nervous system including neurological and psychiatric disorders. Shares of PATH fell by 0.92% or $-0.03/share to $3.23. In the past year, the shares have traded as low as $1.57 and as high as $4.00. On average, 460035 shares of PATH exchange hands on a given day and today's volume is recorded at 1822884.
Source
